UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more
UMediC Group Berhad (0256) - Total Assets
Latest total assets as of October 2025: RM94.93 Million MYR
Based on the latest financial reports, UMediC Group Berhad (0256) holds total assets worth RM94.93 Million MYR as of October 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
UMediC Group Berhad - Total Assets Trend (2020–2025)
This chart illustrates how UMediC Group Berhad’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
UMediC Group Berhad - Asset Composition Analysis
Current Asset Composition (July 2025)
UMediC Group Berhad's total assets of RM94.93 Million consist of 57.9% current assets and 42.1% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 12.7% |
| Accounts Receivable | RM11.18 Million | 12.3% |
| Inventory | RM18.95 Million | 20.8% |
| Property, Plant & Equipment | RM0.00 | 0.0% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM287.00K | 0.3% |
Asset Composition Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: UMediC Group Berhad's current assets represent 57.9% of total assets in 2025, an increase from 56.0% in 2020.
- Cash Position: Cash and equivalents constituted 12.7% of total assets in 2025, up from 11.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 20.8% of total assets.
UMediC Group Berhad Competitors by Total Assets
Key competitors of UMediC Group Berhad based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
JVM Co. Ltd
KQ:054950
|
Korea | ₩296.91 Billion |
UMediC Group Berhad - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - UMediC Group Berhad generates 0.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, UMediC Group Berhad generates $8.92 in net profit.
UMediC Group Berhad - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.22 | 10.32 | 5.32 |
| Quick Ratio | 4.66 | 7.22 | 3.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM47.41 Million | RM 44.89 Million | RM 39.17 Million |
UMediC Group Berhad - Advanced Valuation Insights
This section examines the relationship between UMediC Group Berhad's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.35 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 10.3% |
| Total Assets | RM91.22 Million |
| Market Capitalization | $6.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values UMediC Group Berhad's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: UMediC Group Berhad's assets grew by 10.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for UMediC Group Berhad (2020–2025)
The table below shows the annual total assets of UMediC Group Berhad from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-07-31 | RM91.22 Million | +10.29% |
| 2024-07-31 | RM82.71 Million | +12.85% |
| 2023-07-31 | RM73.29 Million | +6.39% |
| 2022-07-31 | RM68.89 Million | +37.99% |
| 2021-07-31 | RM49.93 Million | +67.09% |
| 2020-07-31 | RM29.88 Million | -- |